68Ga-DOTATOC PET/MRI参数与未治疗神经内分泌肿瘤分级的相关性
前瞻性纳入26例新诊断未治疗神经内分泌肿瘤患者,行68Ga-DOTATOC PET/MRI,评估动脉期和静脉期强化、扩散受限及SUVmax与病理分级的相关性。动脉期强化与分级呈中度负相关(r=-0.35,p=0.005),肝转移、T1w高信号、动脉期高强化、扩散受限及SUVmax高于肝脏水平与侵袭性肿瘤生物学显著相关。
要点
- 动脉期强化与肿瘤分级呈中度负相关(r=-0.35,p=0.005)。
- T1w较肌肉高信号(OR 12.7)、SUVmax高于肝脏水平(OR 7.0)与侵袭性生物学显著相关。
- 肝转移(OR 2.6)、动脉期高强化(OR 1.4)、扩散受限(OR 2.8)亦与侵袭性生物学显著相关。
关键影像表现/征象
- 评估了NEN病灶数目和位置、平扫T1w和T2w及增强动脉期和门静脉期T1w上的主要肿瘤信号强度、ADC和SUVmax。
- 动脉期强化与肿瘤分级呈中度负相关(r=-0.35,p=0.005)。
- 门静脉期强化与Ki-67指数呈弱正相关(r=0.28,p=0.008),与肿瘤分级呈非显著正相关(r=0.19,p=0.063)。
诊断标准与关键数值
- 与侵袭性肿瘤生物学显著相关的特征:肝转移(OR 2.6,p=0.042)、T1w较肌肉高信号(OR 12.7,p=0.0001)、动脉期高强化(OR 1.4,p=0.001)、扩散受限(OR 2.8,p=0.02)、SUVmax高于肝脏水平(OR 7.0,p=0.001)。
临床应用与阅片要点
- 作者认为PET/MRI特征可能有助于预测NEN分级,并对肿瘤侵袭性提供初步评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate a correlation between 68Ga-DOTATOC PET/MR imaging parameters such as arterial and venous contrast enhancement, diffusion restriction, and maximum standardized uptake value (SUVmax) with histopathological tumor grading in patients with neuroendocrine neoplasms (NEN).
MATERIAL AND METHODS: A total of 26 patients with newly diagnosed, therapy-naive neuroendocrine neoplasms (NEN) were enrolled in this prospective study and underwent 68Ga-DOTATOC PET/MRI. Images were evaluated regarding NEN lesion number and location, predominant tumor signal intensity on precontrast T1w and T2w images and on postcontrast arterial and portal venous phase T1w images, apparent diffusion coefficient (ADC) and SUVmax. Histopathological tumor grading was assessed and related to PET/MRI features using Pearson's correlation coefficient and Fisher's exact t-test. A binary logistic regression analysis was performed to evaluate a potential relation with an aggressive tumor biology and odds ratios (OR) were calculated.
RESULTS: There was a moderate negative correlation between arterial contrast enhancement and tumor grading (r=-0.35, p = 0.005), while portal venous enhancement showed a weak positive correlation with the Ki-67 index (r = 0.28, p = 0.008) and a non-significant positive correlation with tumor grading (r = 0.19, p = 0.063). Features that were significantly associated with an aggressive tumor biology were the presence of liver metastases (OR 2.6, p = 0.042), T1w hyperintensity in comparison to muscle (OR 12.7, p = 0.0001), arterial phase hyperenhancement (OR 1.4, p = 0.001), diffusion restriction (OR 2.8, p = 0.02) and SUVmax above the hepatic level (OR 7.0, p = 0.001).
CONCLUSION: The study reveals that PET/MRI features might be useful for prediction of NEN grading and thus provide a preliminary assessment of tumor aggressiveness.
引用
- Bruckmann NM, Rischpler C, Kirchner J, et al. Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid 68Ga-DOTATOC PET/MRI. Eur J Radiol. 2021. PMID: 33639542. doi:10.1016/j.ejrad.2021.109588
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。